about
Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experienceSkipped BSCL2 Transcript in Celia's Encephalopathy (PELD): New Insights on Fatty Acids Involvement, Senescence and AdipogenesisDifferential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides.Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia's encephalopathy.Bone mineral density in familial partial lipodystrophy.Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease.Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: an In vitro and In vivo Study.Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.Lipodystrophic laminopathies: Diagnostic clues.Larger aggregates of mutant seipin in Celia's Encephalopathy, a new protein misfolding neurodegenerative disease.Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administrationInflammatory myopathy in the context of an unusual overlapping laminopathy[Acantosis nigricans in severe insulin resistance syndromes][Uncommon lipodystrophic syndromes]LipoDDx: a mobile application for identification of rare lipodystrophy syndromesDoes Seipin Play a Role in Oxidative Stress Protection and Peroxisome Biogenesis? New Insights from Human Brain Autopsies
P50
Q35547148-717AE851-8594-4A30-845E-C86BF115D7EAQ36071217-DA6216CD-956D-40E4-9955-1977D353EBF0Q39310243-C2BCF406-2E39-4A81-B953-3FCBC3FCDD10Q43204250-EF517093-FAAC-4377-93B2-64C4B2DD7EBEQ44843169-1D9826A4-4E45-48DF-BE21-FA0DBD13F466Q46020477-65C8E895-2EC2-4528-B4D3-58DC82B8591AQ46753075-03D59DF8-2C17-4384-9D34-CFE795900FC8Q47552197-AD919994-37C4-4525-9B42-1074E6E3F845Q47596678-17EE5629-9632-4000-B350-7B558A55797CQ48341358-1A88D3A3-4E5D-475A-8D83-99239D3D8F8FQ49029225-EC3E88FF-ED02-4A46-9E4F-D85109DDD61AQ51606717-AA18A948-8444-45FB-AF0B-3E14723C837EQ51761347-B8F7D79F-585B-4C4F-97D0-733592C191E3Q52923867-3316D8F9-8BD8-4AAB-856A-14BC6CE564F2Q58389223-D736DD64-E275-45C3-8539-E5F5EC703A19Q64869695-44D48B58-21AE-44F8-81E1-925CAE206DBBQ87336739-BED94B8F-0795-4189-A234-0C6189A97CDEQ87793919-9CE4A754-0768-4E18-99E2-FD0E792239DCQ91516400-788B6CF9-0B0A-4FD5-8929-B2ECB37CA338Q93188300-F074B35A-386E-4463-9CDA-DBD616DB7D39
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sofía Sánchez-Iglesias
@ast
Sofía Sánchez-Iglesias
@en
Sofía Sánchez-Iglesias
@es
Sofía Sánchez-Iglesias
@nl
Sofía Sánchez-Iglesias
@sl
type
label
Sofía Sánchez-Iglesias
@ast
Sofía Sánchez-Iglesias
@en
Sofía Sánchez-Iglesias
@es
Sofía Sánchez-Iglesias
@nl
Sofía Sánchez-Iglesias
@sl
prefLabel
Sofía Sánchez-Iglesias
@ast
Sofía Sánchez-Iglesias
@en
Sofía Sánchez-Iglesias
@es
Sofía Sánchez-Iglesias
@nl
Sofía Sánchez-Iglesias
@sl
P106
P1153
6602522323
P31
P496
0000-0003-3887-0573